Tuesday, August 16, 2022
HomeEconomyIndian Share MarketSun, Cipla’s US show tops Dr Reddy’s, Lupin in Q1

Sun, Cipla’s US show tops Dr Reddy’s, Lupin in Q1

Pricing pressure continues to remain a key headwind for the growth of pharma companies in the US market
source

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments